v3 Template
C

Co Diagnostics Inc.

Healthcare and Biotechnology Salt Lake City, USA ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$1.2M
Funding Rounds
1
Last Funding
2023-07-13

About Co Diagnostics Inc.

Co-Dx is a company focused on amplifying human potential through real-time PCR diagnostic testing. Their mission is to empower everyone to take charge of their well-being by developing user-friendly, reliable PCR diagnostic tests for families, businesses, and point-of-care facilities, delivering fast results in around 30 minutes using compact devices.

Products & Services

Co-Dx™ PCR Pro™ Instrument:A platform for rapid real-time PCR testing.
Co-Dx PCR COVID-19 Test Kit:A test kit for detecting COVID-19 using PCR technology.
Co-Dx Box™:A compact, portable qPCR cycler with a fixed optical path, no need for optical calibration, designed for on-site testing.
Diagnostic Solutions:In vitro diagnostic (IVD) products for infectious diseases, compliant with local regulations, including Logix Smart® tests for ABC, COVID-19 (FDA EUA), MTB, SARS-CoV-2, ZDC, and Zika.
Research Solutions:Research Use Only (RUO) products for non-clinical applications, including Logix Smart® tests for ABC, COVID-19, Mpox, SARS-CoV-2, and Maverick Blue® Nucleic Acid Stain.
Vector Control Solutions:PCR tests and equipment like Vector Smart™ NAM-e, NAM-w, and VZDC, designed for mosquito samples to prevent outbreaks of mosquito-borne diseases.

Specialties

Real-time PCR Multiplex Testing Co-Primers Technology Infectious Disease Detection Vector Control At-Home Testing

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant
A: 1200000
MR: -
FA: $1.2 million
FAN: 1200000
D: 2023-07-13
FD: 2023-07-13
1 investors
Grant Latest
2023-07-13
$1.2M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Carl Wittwer

Professor Emeritus of Pathology

K

Karen C. Carroll

Professor of Pathology, Director of the Division of Medical Microbiology at Johns Hopkins University School of Medicine

N

Noriko Kusukawa

Vice President for ARUP Laboratories and Adjunct Associate Professor of Pathology

D

Dwight H. Egan

Chief Executive Officer

R

Richard Abbott

President

B

Brian L. Brown

Chief Financial Officer

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Co Diagnostics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare and Biotechnology
Company Size
~150 employees (est.)
Locations
Salt Lake City, USA
Salt Lake City, Utah, USA; Baroda, India

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro